About Accumetrics
Accumetrics is a Healthcare company based in San Diego (United States) founded in 1996, and was acquired by Accriva Diagnostics in August 2013. It operates as a platelet function assays and coagulation systems are developed and marketed. Accumetrics has raised $97.53 million across 5 funding rounds from investors including Accriva Diagnostics, PTV Healthcare Capital and Arnerich Massena. The company has 46 employees. The company was acqui-hired. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Platelet Function Analyzers. Its competitors include AggreDYNE, ThrombusCheck, COC Pharmaceuticals Industry, Zabit Pharmaceutical and DCM Pharmaceutical Industry; 1 of its 5 listed competitors has raised funding.
Company details
Accumetrics was founded in 1996 in San Diego, United States, within the medical diagnostics sector. The VerifyNow System is developed and marketed as a point-of-care platform for assessing platelet function and patient responses to antiplatelet therapies. Additionally, the Hemochron Signature Elite is offered for coagulation monitoring. Operations focus on rapid, user-friendly assays for clinical use. The company was acquired by ITC Nexus Holding Company in 2013.
- Headquarters San Diego, United States
- Employees 46
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website accumetrics.com
- Acquired by Accriva Diagnostics (Aug 2013)
- Total Equity Funding$97.53M (USD)
in 5 rounds
- Latest Funding Round$30.48M (USD), Series E
Apr 2013
- InvestorsAccriva Diagnostics
& 9 more
- Employee Count46
- Acquired byAccriva Diagnostics
(Aug 2013)
Funding Insights of Accumetrics
Accumetrics has successfully raised a total of $97.53M across 5 strategic funding rounds. The most recent funding activity was a Series E round of $30.48 million completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $97.53M
- Total Rounds 5
- Last Round Series E — $30.48M
- First Round $13.5M
(Jul 2004)
- Investors Count 9
All 5 funding rounds of Accumetrics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2013 | $30.48M | Series E | – | Arnerich Massena, RiverVest Venture Partners | – |
| Oct 2010 | $16.5M | Series E | – | – | |
| Feb 2008 | $28.8M | Series D | – | – | |
| Feb 2006 | $8.25M | Series C | – | RiverVest Venture Partners | |
| Jul 2004 | $13.5M | Series B | – | EW Healthcare Partners |
10 investors in total: 10 institutional.
Investors in Accumetrics
Accumetrics has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Accriva Diagnostics, PTV Healthcare Capital and Arnerich Massena.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | rivervest.com | - | |
Tech and Life Sciences focused corporate VC firm investing in the US | – | kpventures.com | Oakland, United States | |
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | – | ewhealthcare.com | New York, United States | |
Tech & Life Sciences focused VC firm investing in early stage startups in the US | – | kbpartners.com | Highland Park, United States | |
Life Sciences focused VC firm investing in expansion & late stage start-ups in the US | 2003 | ptvhc.com | Austin, United States | |
Venture capital firm focused on life science, medical device and healthcare companies | – | thpartners.net | San Francisco, United States | |
Offers wealth management, investment banking, and strategic advisory services to clients. | 1991 | arnerichmassena.com | Portland, United States | |
- | – | pintovc.com | - | |
Provides independent investment advisory services to clients. | 1979 | fisherinvestments.com | Camas, United States | |
Near-patient diagnostic systems for coagulation testing are developed. | 2009 | accriva.com | San Diego, United States |
Investor details for Accumetrics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Accumetrics
4 dated milestones of Accumetrics across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Accumetrics is founded.
- Funding First funding round of $13.5M.
- Funding Latest funding round, Series E, of $30.5M.
- Exit Acquired by Accriva Diagnostics.
Competitors of Accumetrics
Accumetrics has 5 listed competitors in our database, 1 of them funded. They include AggreDYNE, ThrombusCheck, COC Pharmaceuticals Industry, Zabit Pharmaceutical and DCM Pharmaceutical Industry, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aggredyne.com | 2011 | Houston, United States | $3M | – | Platelet stickiness is measured using patented Aggreguide A-100. | |
| thrombuscheck.com | 2017 | Palo Alto, United States | – | – | Offers a device that mimics plaqued arteries for personalized anti-platelet therapy. | |
| cocpharmaceuticals.com | 2011 | Glasgow, United Kingdom | – | – | Develops diagnostic devices for platelet function analysis. | |
| zabitpharmaceutical.com | 2011 | London, United Kingdom | – | – | Develops innovative devices for platelet functioning tests. | |
| dcmpharmaceutical.com | 2011 | London, United Kingdom | – | – | Creates innovative diagnostic devices for measuring platelet dysfunction in healthcare. |
Detailed competitors of Accumetrics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
10 companies that operate in the same segment as Accumetrics (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | – | 384 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 13 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Accumetrics
Complete news archive for Accumetrics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accumetrics
Accumetrics was founded in 1996 and raised its 1st funding round 8 years after it was founded.
Accumetrics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Accumetrics is a funded company, having raised a total of $97.53M across 5 funding rounds to date. The company's 1st funding round was a Series B of $13.5M, raised on Jul 2004.
Accumetrics has 46 employees.
Accumetrics was founded in 1996 in San Diego, United States, within the medical diagnostics sector. The VerifyNow System is developed and marketed as a point-of-care platform for assessing platelet function and patient responses to antiplatelet therapies. Additionally, the Hemochron Signature Elite is offered for coagulation monitoring. Operations focus on rapid, user-friendly assays for clinical use. The company was acquired by ITC Nexus Holding Company in 2013.
Accumetrics's top competitors include AggreDYNE, ThrombusCheck and COC Pharmaceuticals Industry.
Accumetrics has 10 investors. Key investors include Accriva Diagnostics, PTV Healthcare Capital, Arnerich Massena, RiverVest Venture Partners, and Kaiser Permanente Ventures.
Yes. Accumetrics was acquired by Accriva Diagnostics in August 2013.